ATRION

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ATRION and buy or sell other stocks, ETFs, and their options commission-free!

About ATRI

Atrion Corp. engages in the manufacture and development of products for medical applications. It offers products for cardiovascular, fluid delivery, and ophthalmic. 

CEO
David A. Battat
CEODavid A. Battat
Employees
Employees
Headquarters
Allen, Texas
HeadquartersAllen, Texas
Founded
1944
Founded1944
Employees
Employees

ATRI Key Statistics

Market cap
809.46M
Market cap809.46M
Price-Earnings ratio
64.50
Price-Earnings ratio64.50
Dividend yield
Dividend yield
Average volume
4.97K
Average volume4.97K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$503.24
52 Week high$503.24
52 Week low
$274.98
52 Week low$274.98

Stock Snapshot

With a market cap of 809.46M, ATRION(ATRI) trades at $459.92. The stock has a price-to-earnings ratio of 64.50.

On 2026-03-10, ATRION(ATRI) stock opened at —, reached a high of —, and a low of —.

The ATRION(ATRI)'s current trading volume is 0, compared to an average daily volume of 4.97K.

In the last year, ATRION(ATRI) shares hit a 52-week high of $503.24 and a 52-week low of $274.98.

In the last year, ATRION(ATRI) shares hit a 52-week high of $503.24 and a 52-week low of $274.98.

People also own

Based on the portfolios of people who own ATRI. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.